why choose us

First received: November 20, 2023

Clinical Trial: HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL

Study Status: Completed

Recruit Status: RECRUITING

Condition: Cutaneous T-Cell Lymphoma/Mycosis Fungoides

Study Type: INTERVENTIONAL


Official Title: Pilot Study of HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL

Brief Summary: The objective of this clinical study is to compare the safety and effectiveness of Valchlor versus HyBryte following 12 weeks of treatment.

Read more